Brief: Peptonic Medical Q2 Sales at SEK 11.93 Million
11/08/2023 07:45
Aug 11 (Reuters) - Peptonic Medical Q2 EPS SEK -0.01. * Q2 gross margin 52% * Q2 sales SEK 11.93 million * Q2 gross profit SEK 6.214 million
Recent news on Peptonic Medical AB
See all newsSweden's Peptonic Medical Q2 sales drop, gross margin narrows
Brief: Peptonic Medical Q2 Sales SEK 2.36 Million
Sweden's Peptonic Medical Q1 operating loss narrows on restructuring
Brief: Peptonic Medical Q1 Sales SEK 3.138 Million
Sweden's Peptonic Medical Q4 sales fall, margin improves on restructuring efforts